Shelcal

Jump to

Elder Pharma eyes Rs 100cr from global sales of Shelcal

Elder had sold Shelcal's domestic market rights and 30 other brands to Torrent Pharma last year for Rs 2,000 crore but had retained the rights for the international markets.
Expect Rs 600-700cr sales from overseas biz: Elder Pharma

Elder Pharma recently sold one of its key brands, Shelcal, to Torrent Pharma. Post the sale, Elder is focusing on remaining brands, including Eldervit and Somazina.
Working to cut debt over next 2 years: Elder Pharma

Alok Saxena, Director, Elder Pharma in an interview with CNBC-TV18 spoke about the growth plans of the company. The company has completely restrategise the domestic operations in the last few months.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Shelcal

Elder Pharma eyes Rs 100cr from global sales of Shelcal

Expect Rs 600-700cr sales from overseas biz: Elder Pharma

Working to cut debt over next 2 years: Elder Pharma